Yahoo Web Search

  1. Related topics

    plaque psoriasis treatment
    • Update on U.S. FDA Review of Biologics License Application· 1 day ago

      ... and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License Application (BLA) for bimekizumab for the treatment of moderate to severe plaque psoriasis by the Prescription Drug User Fee Action (PDUFA) date of Oc